Published in Klin Med (Mosk) on January 01, 2002
Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol (1995) 0.97
[Comparative study of the reactivity, safety and immunogenicity of "Havrix" inactivated hepatitis A vaccine]. Vopr Virusol (2001) 0.81
[The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer-subunit influenza vaccine administered to schoolchildren]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.78
[The prophylactic use of dry polyvalent dysentery bacteriopathe with pectin in preschool children's institutions. I. Results of a strictly controlled epidemiologic trial (Yaroslavl, 1968)]. Zh Mikrobiol Epidemiol Immunobiol (1970) 0.77
[Preventive use of dry polyvalent dysentery bacteriophage in preschool institutions. II. Principles of present-day tactics and application schedule of bacteriophage]. Zh Mikrobiol Epidemiol Immunobiol (1971) 0.77
[Use of dysentery bacteriophage as a means of preventing dysentery (review of the literature)]. Zh Mikrobiol Epidemiol Immunobiol (1973) 0.77
Phospholipid composition of high-density lipoproteins reflects lipolysis of triglyceride-rich lipoproteins during hyperlipidemia. Bull Exp Biol Med (2001) 0.75
[Test of the safety, reactogeneity and immunogeneity of live Flexner 2a and Sonne dysentery vaccine from spontaneous mutants, prepared in dragee form, in a controlled experiment on adults]. Zh Mikrobiol Epidemiol Immunobiol (1977) 0.75
[Reactogenicity of a group A and C meningococcal polysaccharide bivalent vaccine]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[The effect of micronized phenofibrate on the lipoproteins of the blood plasma at different initial lipid levels]. Ter Arkh (1996) 0.75
[Chest pains detected on the basis of the WHO standard questionnaire and their prognostic significance]. Ter Arkh (1987) 0.75
[Efficiency and safety of a long-lasting form of diltiazem in the treatment of hypertensive patients with ischemic heart disease]. Klin Med (Mosk) (2002) 0.75
[Comparative study of the immunogenicity of the inactivated hepatitis A vaccine Hep-A-in-vac from experimental and clinical data]. Vopr Virusol (1996) 0.75
[Comparative study of the reactogenicity and immunogenicity of various doses of a chemical polysaccharide meningococcal vaccine administered by syringe and jet injector]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Results of 4 years' follow-up of a group of ambulatory patients with ischemic heart disease (data from the study on multifactor prevention of IHD)]. Ter Arkh (1984) 0.75
[Comparative study of the diagnostic value of Brucella allergens in a controlled epidemiological trial]. Zh Mikrobiol Epidemiol Immunobiol (1987) 0.75
[A comparative evaluation of the immunogenicity and reactogenicity of recombinant vaccines against hepatitis B]. Vopr Virusol (1994) 0.75
[Long-term results of the program for preventing ischemic heart disease in Moscow (10-year follow-up study)]. Kardiologiia (1993) 0.75
[Effect of pyromecaine on ionic currents in electrically excitable membranes]. Biull Eksp Biol Med (1985) 0.75
[Features of the excitatory action of histamine on the smooth muscle of the cecum of the guinea pig]. Fiziol Zh (1989) 0.75
Mortality and morbidity indicators of acute myocardial infarction in participants and non-participants in population studies conducted in Moscow and Kaunas. Cor Vasa (1989) 0.75
[An increased risk of death from ischemic heart disease in men with low blood concentrations of total cholesterol and low-density lipoprotein cholesterol]. Ter Arkh (1993) 0.75
[Parameters of mortality in a program of multifactorial prevention of ischemic heart disease]. Ter Arkh (1991) 0.75
[Comparative clinico-pharmacological characteristics of nimodipine, nifedipine and foridon in the treatment of patients with ischemic stroke in late rehabilitative and residual periods]. Klin Med (Mosk) (2002) 0.75
[Alcohol consumption habits in a population of 40- to 59-year-old men and its prognostic value in relation to mortality]. Ter Arkh (1988) 0.75
[Peculiarities of pharmacotherapy in patients with chronic heart failure]. Klin Med (Mosk) (2006) 0.75
[The prognostic significance of basic risk factors of ischemic heart disease and its changes in carrying out preventive measures]. Ter Arkh (1989) 0.75
[Diagnosis of myocardial infarct with fatal outcome within the framework of multifactorial prevention of ischemic heart disease in Moscow]. Kardiologiia (1991) 0.75
[The prophylactic efficacy of the trivalent polymer-subunit influenza vaccine Grippol (3)]. Voen Med Zh (1997) 0.75
[The efficacy of recombinant vaccines against hepatitis B and the results of their use in a schedule for pediatric prophylactic inoculations]. Zh Mikrobiol Epidemiol Immunobiol (1998) 0.75
[Prevention of myocardial infarction: priorities, principles, realities]. Klin Med (Mosk) (1996) 0.75
[Effect of diethyphen on cerebral vessel tonus and on general arterial pressure]. Farmakol Toksikol (1977) 0.75
[The clinical efficacy of Korinfar-retard in combination with Cordanum, triampur and Capoten in patients with arterial hypertension]. Klin Med (Mosk) (1996) 0.75
[Characteristics of "Avaxim" hepatitis A vaccine produced by the firm "Pasteur Merrier" (results of field clinical trials)]. Vopr Virusol (2000) 0.75
[Toxicologic characteristics of crown ethers and the semi-products of their synthesis]. Gig Tr Prof Zabol (1987) 0.75
[The pharmacoepidemiology of drugs used in treatment of patients with chronic obstructive pulmonary disease]. Klin Med (Mosk) (2006) 0.75
[Status and outlook for improving serological methods of diagnosing dysentery in clinical and epidemiological practice (literature review)]. Zh Mikrobiol Epidemiol Immunobiol (1974) 0.75
[The pharmacokinetic and pharmacodynamic characteristics of foridon during interaction with the metabolic oxidation inhibitor dopegit]. Eksp Klin Farmakol (1994) 0.75
[Evaluation of reactivity and immunogenicity of a cultured concentrated inactivated vaccine against hepatitis A "Hep-A-In-Vak"]. Vopr Virusol (1996) 0.75
[The clinical pharmacology and efficacy of the new Soviet calcium antagonist foridon]. Ter Arkh (1990) 0.75
[Hep-A-in-Vac, a Russian cultured concentrated inactivated vaccine against hepatitis A]. Zh Mikrobiol Epidemiol Immunobiol (1998) 0.75
[Reactogenicity and immunologic activity of live enteric Sonne dysentery vaccine from a spontaneous mutant]. Zh Mikrobiol Epidemiol Immunobiol (1977) 0.75
[Prognostic significance of total blood cholesterol level and the possibility of dietary correction of hypercholesterolemia in the population]. Kardiologiia (1989) 0.75
[Content of A-, G- and M-class immunoglobulins in adults perorally immunized with a liver Sonne dysentery vaccine]. Zh Mikrobiol Epidemiol Immunobiol (1978) 0.75
[Russian recombinant vaccine against hepatitis B (results of controlled trials)]. Vopr Virusol (1997) 0.75
[Safety, reactogenicity and immunological activity of a group A meningococcal polysaccharide vaccine for children 1-4 years old]. Zh Mikrobiol Epidemiol Immunobiol (1987) 0.75
[Nutritional status of patients with various disorders of carbohydrate metabolism. Epidemiologic single study]. Vopr Pitan (1997) 0.75
[Effect of verapamil on cerebral circulation]. Biull Eksp Biol Med (1978) 0.75
[Comparative study of the sensitivity and specificity of dried and liquid meningococcal erythrocyte diagnostic agents A, C and Y in a controlled trial]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75
[Evaluation of the effectiveness of influenza trivalent polymer subunit vaccine "Grippol"]. Zh Mikrobiol Epidemiol Immunobiol (1998) 0.75
[Pharmacokinetic and pharmacodynamic effects of isradipine in patients with arterial hypertension]. Eksp Klin Farmakol (2003) 0.75
[Effect of multiple gamma globulin administration on the effectiveness of seroprophylaxis in hepatitis A]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75
[Safety and reactogenicity of a group-A meningoccal polysaccharide vaccine for children 5 to 14]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[A prospective study on mortality and incidence of myocardial infarct and stroke in male population 40-59 years of age at different risk levels]. Kardiologiia (1990) 0.75
[Diabetes mellitus: its prevalence, relationship to the risk factors for IHD and prognostic importance (an epidemiological study)]. Ter Arkh (1996) 0.75
[Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm]. Vopr Virusol (1996) 0.75
[The results of the registration clinical trials of the Act-Hib vaccine manufactured by the firm of Pasteur Mérieux Connaught, France]. Zh Mikrobiol Epidemiol Immunobiol (1999) 0.75